A Phase 3 Global, Double-Blind, Randomized, Placebo???Controlled Study to Evaluate the Efficacy andSafety of ION-682884 in Patientswith Transthyretin???Mediated Amyloid Cardiomyopathy(ATTR CM)

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.